Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sumitomo Pharma Co., Ltd.
Age
18–74
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient meets DSM-IV criteria for schizophrenia.
Patient is 18 or older but younger than 75 years of age on the day of signing informed consent.
Patient understands the objectives, nature, and other aspects of the study and voluntarily agrees to participate in the study by providing written informed consent.
You may not be if
Patient has a history of neuroleptic malignant syndrome, water intoxication, or paralytic ileus.
Patient has Parkinson's disease.
Patient has a history or complication of malignancy.
Clareo Health | Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia
